ENSG00000263761


Homo sapiens

Features
Gene ID: ENSG00000263761
  
Biological name :GDF2
  
Synonyms : GDF2 / growth differentiation factor 2 / Q9UK05
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 10
Strand: 1
Band: q11.22
Gene start: 47322490
Gene end: 47326270
  
Corresponding Affymetrix probe sets: 221136_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000463051
NCBI entrez gene - 2658     See in Manteia.
OMIM - 605120
RefSeq - NM_016204
RefSeq Peptide - NP_057288
swissprot - Q9UK05
Ensembl - ENSG00000263761
  
Related genetic diseases (OMIM): 615506 - Telangiectasia, hereditary hemorrhagic, type 5, 615506
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 gdf2ENSDARG00000059173Danio rerio
 GDF2ENSGALG00000005981Gallus gallus
 Gdf2ENSMUSG00000072625Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
BMP10 / O95393 / bone morphogenetic protein 10ENSG0000016321740
BMP4 / P12644 / bone morphogenetic protein 4ENSG0000012537828
BMP2 / P12643 / bone morphogenetic protein 2ENSG0000012584527
BMP5 / P22003 / bone morphogenetic protein 5ENSG0000011217527
BMP6 / P22004 / bone morphogenetic protein 6ENSG0000015316227
BMP8B / P34820 / bone morphogenetic protein 8bENSG0000011698527
BMP7 / P18075 / bone morphogenetic protein 7ENSG0000010114426
BMP8A / Q7Z5Y6 / bone morphogenetic protein 8aENSG0000018368226
GDF6 / Q6KF10 / growth differentiation factor 6ENSG0000015646624
GDF7 / Q7Z4P5 / growth differentiation factor 7ENSG0000014386921
GDF5 / P43026 / growth differentiation factor 5ENSG0000012596521


Protein motifs (from Interpro)
Interpro ID Name
 IPR001111  TGF-beta, propeptide
 IPR001839  Transforming growth factor-beta, C-terminal
 IPR015615  Transforming growth factor-beta-related
 IPR017948  Transforming growth factor beta, conserved site
 IPR029034  Cystine-knot cytokine


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0001503 ossification TAS
 biological_processGO:0001525 angiogenesis IMP
 biological_processGO:0001569 branching involved in blood vessel morphogenesis IDA
 biological_processGO:0001570 vasculogenesis IEA
 biological_processGO:0001649 osteoblast differentiation IEA
 biological_processGO:0001937 negative regulation of endothelial cell proliferation IDA
 biological_processGO:0001938 positive regulation of endothelial cell proliferation IDA
 biological_processGO:0006879 cellular iron ion homeostasis TAS
 biological_processGO:0008156 negative regulation of DNA replication TAS
 biological_processGO:0010469 regulation of signaling receptor activity IEA
 biological_processGO:0010596 negative regulation of endothelial cell migration IDA
 biological_processGO:0010628 positive regulation of gene expression IEA
 biological_processGO:0010862 positive regulation of pathway-restricted SMAD protein phosphorylation IDA
 biological_processGO:0016525 negative regulation of angiogenesis TAS
 biological_processGO:0030308 negative regulation of cell growth IDA
 biological_processGO:0030509 BMP signaling pathway TAS
 biological_processGO:0030513 positive regulation of BMP signaling pathway IEA
 biological_processGO:0032757 positive regulation of interleukin-8 production IDA
 biological_processGO:0032924 activin receptor signaling pathway IDA
 biological_processGO:0042981 regulation of apoptotic process IBA
 biological_processGO:0043408 regulation of MAPK cascade IBA
 biological_processGO:0043537 negative regulation of blood vessel endothelial cell migration TAS
 biological_processGO:0045603 positive regulation of endothelial cell differentiation IEA
 biological_processGO:0045669 positive regulation of osteoblast differentiation IEA
 biological_processGO:0045766 positive regulation of angiogenesis IEA
 biological_processGO:0045893 positive regulation of transcription, DNA-templated IEA
 biological_processGO:0045944 positive regulation of transcription by RNA polymerase II IEA
 biological_processGO:0048468 cell development IBA
 biological_processGO:0048514 blood vessel morphogenesis IDA
 biological_processGO:0051216 cartilage development TAS
 biological_processGO:0060389 pathway-restricted SMAD protein phosphorylation IDA
 biological_processGO:0060395 SMAD protein signal transduction IBA
 biological_processGO:0061036 positive regulation of cartilage development IEA
 biological_processGO:0071773 cellular response to BMP stimulus IDA
 biological_processGO:2000279 negative regulation of DNA biosynthetic process IDA
 cellular_componentGO:0005576 extracellular region TAS
 cellular_componentGO:0005615 extracellular space IBA
 cellular_componentGO:0005623 cell IEA
 cellular_componentGO:0070062 extracellular exosome HDA
 molecular_functionGO:0005125 cytokine activity IBA
 molecular_functionGO:0005160 transforming growth factor beta receptor binding IBA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0008083 growth factor activity IEA


Pathways (from Reactome)
Pathway description
Signaling by BMP


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000421 Epistaxis 
Show

 HP:0000524 Conjunctival telangiectasia "The presence of small (ca. 0.5-1.0 mm) dilated blood vessels near the surface of the mucous membranes of the conjunctiva." [HPO:curators]
Show

 HP:0000646 Amblyopia "Reduced visual acuity that is uncorrectable by lenses in the absence of detectable anatomic defects in the eye or visual pathways. Ambylopia can result from visual deprivation during the critical period of development of visual abilities which lasts to about the age of 8 years. Thus, ambylopia can result from strabismus, anisometropia, or high hypermetropia in there is a failure to form a focused image in one or both eyes." [HPO:curators]
Show

 HP:0000787 Kidney stones 
Show

 HP:0000790 Hematuria "The presence of blood in the urine. Hematuria may be gross hematuria (visible to the naked eye) or microscopic hematuria (detected by dipstick or microscopic examination of the urine)." [HPO:curators]
Show

 HP:0001009 Telangiectasia "Telangiectasias refer to small dilated blood vessels located near the surface of the skin or mucous membranes, measuring between 0.5 and 1 millimeter in diameter." [HPO:curators]
Show

 HP:0001048 Cavernous hemangioma "The presence of a cavernous hemangioma. A hemangioma characterized by large endothelial spaces (caverns) is called a cavernous hemangioma." [HPO:curators]
Show

 HP:0001081 Cholelithiasis 
Show

 HP:0001082 Cholecystitis 
Show

 HP:0001250 Seizures "Seizures are an intermittent `abnormality of the central nervous system` (FMA:HP:0002011) due to a sudden, excessive, disorderly discharge of cerebral neurons and characterized clinically by some combination of disturbance of sensation, loss of consciousness, impairment of psychic function, or convulsive movements." [HPO:probinson]
Show

 HP:0001342 Cerebral hemorrhage "A cerebral hemorrhage (or intracerebral hemorrhage, ICH), is a type of intracranial hemorrhage that occurs within the brain tissue itself." [HPO:curators]
Show

 HP:0001394 Cirrhosis 
Show

 HP:0001399 Hepatic failure 
Show

 HP:0001409 Portal hypertension 
Show

 HP:0001635 Congestive heart failure "The presence of an abnormality of cardiac function that is responsible for the failure of the heart to pump blood at a rate that is commensurate with the needs of the tissues or a state in which abnormally elevated filling pressures are required for the heart to do so. Heart failure is frequently related to a defect in myocardial contraction." [HPO:curators]
Show

 HP:0001935 Microcytic anemia 
Show

 HP:0002040 Esophageal varices 
Show

 HP:0002076 Migraine 
Show

 HP:0002092 Pulmonary hypertension 
Show

 HP:0002105 Hemoptysis "Coughing up (expectoration) of blood or blood-streaked sputum from the larynx, trachea, bronchi, or lungs." [HPO:curators]
Show

 HP:0002138 Subarachnoid hemorrhage 
Show

 HP:0002204 Pulmonary embolism 
Show

 HP:0002239 Gastrointestinal hemorrhage 
Show

 HP:0002326 Transient ischemic attack 
Show

 HP:0002910 Elevated transaminases "Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage." [HPO:curators]
Show

 HP:0004406 Spontaneous, recurrent epistaxis 
Show

 HP:0004936 Venous thrombosis 
Show

 HP:0007420 Spontaneous hematomas 
Show

 HP:0007763 Retinal telangiectasia 
Show

 HP:0100585 Teleangiectasia of the skin 
Show

 HP:0100761 Visceral angiomatosis 
Show

 HP:0100784 Peripheral arteriovenous fistula 
Show

 HP:0200008 Multiple intestinal polyps 
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000139567 ACVRL1 / P37023 / activin A receptor like type 1  / reaction / complex
 ENSG00000263761 GDF2 / Q9UK05 / growth differentiation factor 2  / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr